Federal drug enforcement officials are facing growing scrutiny after a former DEA agent alleged that investigators allowed large fentanyl shipments to move through New Mexico as part of long-term operations targeting larger trafficking networks.
The allegations, first reported by the Associated Press and based on whistleblower testimony, have triggered anger from state and local officials in New Mexico, where fentanyl deaths remain a major public health crisis. The central question is whether federal agents made lawful investigative decisions to build larger cases, or whether they put communities at risk by allowing dangerous drugs to reach the streets.
Former DEA special agent David Howell reportedly claimed that agents had detailed intelligence about fentanyl shipments into Albuquerque, including information about quantities and delivery locations, but did not immediately seize the drugs. He alleged that investigators “sat back and watched” in some cases while pursuing broader trafficking investigations.
The DEA has strongly disputed descriptions suggesting it knowingly allowed fentanyl to harm communities. The agency said the cases involved complex, court-authorized investigations using surveillance, intelligence gathering and coordination with federal prosecutors. According to the DEA, operational decisions were lawful, reasonable and consistent with Justice Department guidance.
TRENDING TODAY
Still, the agency has asked the Justice Department’s inspector general to review Howell’s complaint. New Mexico Attorney General Raúl Torrez has also opened a formal investigation into the allegations, saying families affected by the fentanyl crisis deserve a full accounting of what federal officials knew and how they acted.
The controversy has struck a nerve in New Mexico because the state has been hit hard by overdose deaths. While national drug fatalities have declined in recent years, New Mexico has continued to struggle, particularly in communities along long-established trafficking routes. Local officials say any suggestion that federal agents knowingly allowed fentanyl to circulate is deeply troubling.
Fentanyl is a synthetic opioid that can be far more potent than heroin and is frequently pressed into counterfeit pills. Because even small amounts can be deadly, law enforcement agencies have often warned that preventing distribution is a public-safety priority. That is why the whistleblower allegations are so politically explosive: the DEA’s public message is that “one pill can kill,” while critics now ask whether agents delayed seizures in pursuit of larger cases.
Federal investigations sometimes allow controlled deliveries or delayed seizures in order to identify higher-level traffickers, suppliers and distribution networks. Supporters of that approach argue that arresting only low-level couriers may not stop the broader pipeline. They say larger cases can save more lives over time by disrupting entire organizations.
Critics counter that fentanyl is too dangerous for that kind of risk. If pills are not seized quickly, they can disappear into the market, be sold to users and potentially contribute to overdoses before investigators complete their case. For families who have lost loved ones, the argument that a bigger case may come later can feel impossible to accept.
The legal issue may depend on what agents knew, what prosecutors approved, what risks were assessed and whether the drugs were tracked or allowed to move beyond law enforcement control. Internal Justice Department guidance has reportedly shifted over time, giving investigators some discretion while also emphasizing that public safety must remain paramount.
For New Mexico residents, the dispute is not abstract. Fentanyl has devastated families, strained emergency rooms, overwhelmed treatment systems and placed pressure on police, first responders and local governments. If federal decisions contributed to more pills reaching communities, officials say the public deserves answers.
The allegations also raise questions about accountability inside federal law enforcement. Whistleblowers often face professional consequences after speaking out, while agencies argue that public reporting can oversimplify complex investigations. An inspector general review may help determine whether rules were followed and whether any policy changes are needed.
Some details remain disputed, including how many shipments were allowed to continue, how much fentanyl reached the street, whether specific deaths can be linked to those decisions, and whether prosecutors approved each investigative step.
Until those questions are answered, the case will remain a major test of public trust in the DEA’s handling of the fentanyl crisis.
Why It Matters
The allegations go to the heart of public safety and federal accountability. If agents delayed fentanyl seizures to build larger cases, investigators must explain how they balanced law enforcement goals against the risk to families, users and communities already devastated by overdoses.
What Comes Next
The Justice Department’s inspector general and New Mexico officials are expected to review the whistleblower claims. Lawmakers may also seek hearings or documents, while the DEA is likely to defend its investigative decisions as lawful and coordinated with prosecutors.
New Mexico officials are demanding answers after allegations that federal drug agents allowed fentanyl shipments to move through the state during long-term investigations.
New Mexico governor demands federal reparations after accusing DEA of fueling state’s fentanyl crisis https://t.co/ke4d654L7V pic.twitter.com/w5VfldKlEF
— New York Post (@nypost) June 30, 2026
